Novo Nordisk's semaglutide, which could be the first oral ... "Delivering protein-based medicine like semaglutide in the form of a tablet and producing it on a large scale is a major challenge ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.

Novo Nordisk is taking a page out of Eli Lilly’s playbook as the two GLP-1 drugmakers work to fend off compounding pharmacies ...

The cost of compounded versions of semaglutide sold by online telehealth providers ranged from $150 to $280 for a month’s supply. “Novo Nordisk continues to advance solutions for patients that ...

The FDA had listed semaglutide in shortage for more than two years as Novo Nordisk struggled to meet the seemingly bottomless demand for its appetite-suppressing drugs. Under government rules ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

For eligible patients, health care providers can send Wegovy prescriptions directly to NovoCare Pharmacy. Novo Nordisk is providing direct-to-patient delivery of Wegovy ® (semaglutide) through ...